Via De Telegraaf: Minister De Jonge: ’13 Omicron infections on Schiphol flights'. The Google translation:
THE HAGUE - During the explanation of Health Minister Hugo de Jonge, it was announced that at least 13 people among the Dutch passengers from South Africa were infected with the omicron variant. No additional measures against this corona variant were announced on Sunday.
Of the more than 600 passengers who arrived in two planes from Cape Town and Johannesburg at Schiphol, it was previously found that 61 had tested positive for corona. The new virus variant has been identified in thirteen of them, the RIVM reports.
The infected passengers are currently staying in a corona hotel near Schiphol Airport. People with complaints must stay there for seven days. Security is available.
Corona test street Schiphol
Travelers who have returned from southern Africa since last Monday are urged by De Jonge to be tested and to go into quarantine. From Sunday they can make an appointment via the special number 0800-5005.
People returning from South Africa via Schiphol can also have themselves tested for the corona virus at the airport from Sunday immediately after arrival. The GGD Kennemerland has set up a special test street at the airport for this purpose.
These are travelers from South Africa, Namibia, Botswana, Zimbabwe, Mozambique, Malawi, Lesotho and Eswatini (Swaziland). These countries now have an entry ban for non-EU citizens. The Dutch can still travel back and forth to southern Africa. Upon return to the Netherlands, they must have a double negative test result and must be in home isolation for at least five days on arrival. According to De Jonge, the municipality is coming to check whether they are actually staying at home.
Belgium was the first European country where the variant was established, followed on Saturday by England and Germany. The World Health Organization (WHO) has given the variant the stamp of concern, but as yet it is unclear what the consequences are for the severity of the disease and the effectiveness of vaccines.